Schizophrenia, Psychosis and Bipolar Disorder

A selection of articles focusing on the pharmacological management of schizophrenia, psychosis and bipolar disorder.

Submit your manuscript to this collection through the participating journal.

Journal

CNS Drugs

CNS Drugs provides researchers and healthcare professionals with essential information on the most important aspects of drug therapies used for the management of neurological and...

Submit to this journal Submission guidelines

Showing 1-26 of 26 articles

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial
John M. Kane
Roy Eshet
Christoph U. Correll
Original Research Article Open access 02 July 2024 Pages: 625 - 636
Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics
Orwa Albitar
Sabariah Noor Harun
Siti Maisharah Sheikh Ghadzi
Original Research Article 05 June 2024 Pages: 571 - 581
Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia
Megan Galbally
Karen Wynter
Susanna Every-Palmer
Original Research Article Open access 07 May 2024 Pages: 559 - 570
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
Hasan Çağın Lenk
Robert Løvsletten Smith
Espen Molden
Original Research Article Open access 18 April 2024 Pages: 473 - 480
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis
Fernando L. Pagan
Paul E. Schulz
Gregory M. Pontone
Therapy in Practice Open access 08 April 2024 Pages: 333 - 347
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
Sarah Smessaert
Johan Detraux
Marc De Hert
Systematic Review 18 January 2024 Pages: 105 - 123
Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
Xin Li
Chong Ye
Gang Wang
Original Research Article Open access 08 January 2024 Pages: 55 - 65
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
Chuanjun Zhuo
Qiuyu Zhang
Deguo Jiang
Review Article Open access 14 December 2023 Pages: 33 - 44
Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis
Qian Li
Xin Li
Tianmei Si
Systematic Review Open access 25 July 2023 Pages: 695 - 713
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Jonathan M. Meyer
Christoph U. Correll
Leading Article Open access 20 July 2023 Pages: 545 - 570
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options
Jose M. Rubio
Daniel Guinart
Christoph U. Correll
Systematic Review 01 June 2023 Pages: 499 - 512
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder
Matthew Harlin
Murat Yildirim
Frank Larsen
Original Research Article Open access 24 March 2023 Pages: 337 - 350
A 10-Year Observational Study of the Use, Acceptability and Effectiveness of Long-Acting Paliperidone Palmitate: Implications for Clinical Decision Making
Sofia Pappa
Joshua Barnett
Katy Mason
Original Research Article 10 December 2022 Pages: 107 - 116
Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
Chien-Yi Kuo
Chieh-Hsin Lin
Hsien-Yuan Lane
Leading Article 04 October 2022 Pages: 1143 - 1153
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
Tanja Veselinović
Irene Neuner
Review Article Open access 13 July 2022 Pages: 819 - 858
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
Maria Carolina Bittencourt Gonçalves
Roberta Andrejew
Carolina Gubert
Leading Article Open access 13 July 2022 Pages: 787 - 801
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C. U. Correll
Ofer Agid
Oliver D. Howes
Therapy in Practice Open access 27 June 2022 Pages: 659 - 679
Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain
Madeline M. Corrao
Leigh Anne Nelson
Review Article 30 May 2022 Pages: 605 - 616
Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis
Niall M. McGowan
David S. Kim
Kate E. A. Saunders
Systematic Review 19 March 2022 Pages: 345 - 363
Alternative Routes of Administration of Clozapine
Siobhan Gee
David Taylor
Current Opinion 03 February 2022 Pages: 105 - 111
Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
Arne W. Mould
Noura Al-Juffali
Elizabeth M. Tunbridge
Leading Article 20 December 2021 Pages: 1 - 16
The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging Studies
Emilio Bergamelli
Lorenzo Del Fabro
Paolo Brambilla
Review Article Open access 12 November 2021 Pages: 1275 - 1287
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
Joshua T. Kantrowitz
Leading Article 15 October 2021 Pages: 1153 - 1161
Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment
Yue Xu
Nousayhah Amdanee
Xiangrong Zhang
Review Article 24 August 2021 Pages: 1265 - 1274
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients
Lennart Kyllesø
Robert Løvsletten Smith
Espen Molden
Original Research Article Open access 20 August 2021 Pages: 999 - 1008
The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study
Arnold P. M. van der Lee
Ibrahim Önsesveren
Niels C. L. Mulder
Original Research Article Open access 10 April 2021 Pages: 451 - 460

Schizophrenia, Psychosis and Bipolar Disorder

Participating journal

CNS Drugs

Articles

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial

Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics

Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia

Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data

On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis

Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review

Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia

Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia

Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

A 10-Year Observational Study of the Use, Acceptability and Effectiveness of Long-Acting Paliperidone Palmitate: Implications for Clinical Decision Making

Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain

Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis

Alternative Routes of Administration of Clozapine

Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia

The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging Studies

Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions

Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment

Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients

The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study

Navigation

Schizophrenia, Psychosis and Bipolar Disorder

Participating journal

Articles

Search

Navigation